Skip to content

Magí Farré

14 papers in the library · 258 citations · publishing 2005-2026

Papers

Sort Most recent Most cited

Symmetrical Global Mental Health (Sym-GMH): Ayahuasca and shipibo traditional medicine for lasting changes in personality and quality of life

Psychedelics April 20, 2026 José Carlos Bouso, Óscar Andión, Jordi Cantillo et al.

The Symmetrical Global Mental Health (Sym-GMH) paradigm proposes a reciprocal integration between traditional and Western medical systems. This prospective, longitudinal study evaluates the psychological outcomes of 264 Western participants who engaged in Shipibo-led ayahuasca retreats at the Temple of the Way of Light in the Peruvian Amazon. Over a 12-month period, participants completed...

DOI: 10.1016/j.psyche.2026.100018 (opens in new tab) Ayahuasca Global mental health Personality Quality philosophy +3

Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial.

Scientific Reports September 1, 2025 Oscar Soto-Angona, Óscar Andión, Pablo Sabucedo et al. 3 citations

Preliminary evidence suggests that ayahuasca may alleviate severe grief symptoms. This three-arm, sequentially allocated, open-label study examines the therapeutic changes associated with ayahuasca-assisted meaning reconstruction therapy (A-MR) compared to meaning reconstruction therapy alone (MR) and a no-treatment control (NT). A total of 84 adults experiencing severe grief within 12 months...

Acute pharmacological effects of α-PVP in humans: a naturalistic observational study.

Frontiers in Pharmacology 2025 Georgina de la Rosa, Esther Papaseit, Olga Hladun et al. 7 citations

Alpha-pyrrolidinopentiophenone (α-PVP) is a commonly consumed analogue of pyrovalerone, a synthetic cathinone with psychostimulant properties similar to those of 3,4-Methylenedioxypyrovalerone (MDPV) and cocaine. Since the pharmacology of α-PVP remains scarcely studied, we aimed to evaluate the acute pharmacological effects and its abuse potential in humans after intranasal administration. We...

DOI: 10.3389/fphar.2025.1626692 (opens in new tab) Full text (opens in new tab) Cathinones New psychoactive substances Alpha-pyrrolidinopentiophenone α-pvp α-pvp Synthetic cathinone +12

Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol.

Frontiers in Psychiatry 2024 Pablo Sabucedo, Óscar Andión, Robert A Neimeyer et al. 4 citations

Psychotherapy for Prolonged Grief Disorder (PGD), a condition characterized by an intense and persistent grief response, has received increased attention over the past decades. Evidence-based approaches to prevent PGD are currently scarce, and not always effective. This paper introduces a protocol for a clinical trial exploring the effectiveness of a Meaning Reconstruction psychotherapy...

Drug and MDMA Interactions Implications for Public Health

Handbook of Substance Misuse and Addictions 2022 Esther Papaseit, Magí Farré, Clara Pérez‐mañá

Public health focused on drug use is considered a balancing act between preventing illicit use of drugs of abuse and ensuring access to drugs/medicines with abuse potential for a medical condition. Whereas clinically relevant drug interactions for medicines are widely recognized and are included in most pharmacovigilance systems, drug interactions with drugs of abuse are mainly underexplored,...

DOI: 10.1007/978-3-030-67928-6_121-1 (opens in new tab) Full text (opens in new tab) MDMA 3,4-methylenedioxymethamphetamine Drug of abuse Drug/medicine +8

Mephedrone and Alcohol Interactions in Humans

Frontiers in Pharmacology January 28, 2020 Esther Papaseit, Clara Pérez‐mañá, Elizabeth B. de Sousa Fernandes Perna et al. 27 citations

Mephedrone (4-MMC, mephedrone) is a synthetic cathinone derivative included in the class of new psychoactive substances. It is commonly used simultaneously with alcohol (ethanol). The aim of the present study was to evaluate the interactions on subjective, cardiovascular and hormone effects and pharmacokinetics between mephedrone and alcohol in humans. Eleven male volunteers participated as...

DOI: 10.3389/fphar.2019.01588 (opens in new tab) Full text (opens in new tab) 4-methylmethcathinone mephedrone New psychoactive substance Alcohol ethanol Interaction +2

Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.

Psychopharmacology April 9, 2019 Vincent T Mensen, Annabel Vreeker, Johan Nordgren et al.

Background: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like "spice" or "incense." A limited number of studies have reported serious health effects associated with SC use. In this study,...

DOI: 10.1007/s00213-019-05238-8 (opens in new tab) Full text (opens in new tab) Humans Marijuana abuse Cannabinoids Marijuana smoking +16

Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart.

European Neuropsychopharmacology October 2015 Magí Farré, Angels Tomillero, Clara Pérez‐mañá et al.

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is a popular psychostimulant, frequently associated with multiple administrations over a short period of time. Repeated administration of MDMA in experimental settings induces tolerance and metabolic inhibition. The aim is to determine the acute pharmacological effects and pharmacokinetics resulting from two consecutive 100mg doses of MDMA...

Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users.

Journal of Psychiatric Research April 2014 Jesus Pujol, Laura Blanco‐Hinojo, Albert Batalla et al.

Recreational drugs are generally used to intentionally alter conscious experience. Long-lasting cannabis users frequently seek this effect as a means to relieve negative affect states. As with conventional anxiolytic drugs, however, changes in subjective feelings may be associated with memory impairment. We have tested whether the use of cannabis, as a psychoactive compound, is associated with...

Consumption of new psychoactive substances in a Spanish sample of research chemical users.

Human Psychopharmacology: Clinical and Experimental July 1, 2013 Débora González, Mireia Ventura, Fernando Caudevilla et al. 39 citations

To know the pattern of use of new psychoactive substances (NPSs) in a Spanish sample of research chemical (RC) users and to deepen the RC user profile and risk reduction strategies employed. This study is a cross-sectional survey by means of a specific questionnaire. Recruitment was carried out at music festivals, at non-governmental organizations (NGOs), and through announcements on an online...

DOI: 10.1002/hup.2323 (opens in new tab) Full text (opens in new tab) 2c-b Consumption patterns New psychoactive substances Research chemicals +12

4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.

Journal of Psychopharmacology July 1, 2012 Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura et al. 99 citations

4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a psychoactive analogue of mescaline that is becoming increasingly popular as a rave and club drug. We investigated its presence in the illicit drug market in Spain, its pattern of use and profile of subjective effects. Drug material was analysed for 2C-B and information on pattern of use and subjective effects was obtained from recreational users....

DOI: 10.1177/0269881111431752 (opens in new tab) Full text (opens in new tab) 2c-b drug Synthetic drug 2c-b 2c-b substance Drug trends +18

5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.

Addiction Biology January 2010 Rocío Martín‐Santos, Marta Torrens, Sandra Poudevida et al.

A 3-year longitudinal prospective study was conducted to compare the incidence of substance use disorders (SUD) and non-substance use disorders (NSUD) among ecstasy users and two control groups: one of cannabis users and the other of non-drug users. The 5-HTTLPR polymorphism related to NSUD was also studied. A total of 94 subjects were included: 37 ecstasy users, 23 cannabis users and 34...

Psychoactive drug or mystical incense? Overview of the online available information on Spice products

International Journal of Culture and Mental Health December 1, 2009 Fabrizio Schifano, Ornella Corazza, Paolo Deluca et al. 79 citations

The aim of the study was to foster the collection and analysis of data from web pages related to information on the consumption, manufacture and sale of Spice products, a brand name for an herbal smoking blend, sold as legal substitute for cannabis. The Google search engine was used to carry out an 8-language qualitative assessment of information available on Spice products in a sample of about...

DOI: 10.1080/17542860903350888 (opens in new tab) Cannabis Spice Popularity World wide web +1

Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.

Clinical Pharmacokinetics 2005 Mireia Segura, Magí Farré, Simona Pichini et al.

3,4-Methylenedioxymethamphetamine (MDMA) is a synthetic amphetamine derivative typically used for recreational purposes. The participation of cytochrome P450 (CYP) 2D6 in the oxidative metabolism of MDMA may suggest an increased risk of acute toxicity in CYP2D6 poor metabolisers. This study was aimed at assessing the contribution of CYP2D6 to MDMA disposition in vivo using paroxetine as a...